Consensus Becton, Dickinson and Company Deutsche Boerse AG

Stocks

BOX

US0758871091

Medical Equipment, Supplies & Distribution

Real-time Estimate Tradegate 04:21:25 2026-09-10 am EDT			5-day change	1st Jan Change
155.20 ^EUR	+0.29%		-4.12%	-6.55%

Sep. 09	Becton, Dickinson and Company Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-08-2026 through Sep-10-2026
Sep. 01	Medtronic Raises Full-Year Outlook Following Fiscal First-Quarter Beat	MT

07420da7dd8ea24314f8e.NC4L39AiqjENArVHBase4K-s3Sad9ZXDNEsWd0FxQ90.VW1N8uNJ8khmRNlyd_wqspncnEzzjcOSaxxYAg8_DrNZZVyNqEXaRGxF_A~747e625ebc71c62b1aee20e42fff9431

Analysts' recommendations: Becton, Dickinson and Company

Aug. 31	BofA Adjusts Price Target on Becton Dickinson and Co. to $200 From $185	MT
Aug. 13	Becton, Dickinson's Consistent Mid-Single-Digit Organic Growth is 12-18 Months Away, RBC Says	MT
Aug. 13	Citigroup Adjusts Price Target on Becton Dickinson and Co. to $208 From $204, Maintains Buy Rating	MT
Aug. 13	RBC Adjusts PT on Becton Dickinson and Co. to $190 From $180, Keeps Sector Perform Rating	MT
Aug. 12	UBS Adjusts Becton Dickinson and Co. PT to $205 From $190, Maintains Buy Rating	MT
Aug. 07	Wells Fargo Adjusts Price Target on Becton Dickinson and Co. to $170 From $161	MT
Aug. 07	Jefferies Adjusts Price Target on Becton Dickinson and Co. to $210 From $190	MT
Aug. 07	Citigroup Adjusts Price Target on Becton Dickinson and Co. to $204 From $198	MT
Aug. 07	Piper Sandler Adjusts Price Target on Becton Dickinson and Co. to $175 From $161	MT
Aug. 07	JPMorgan Adjusts Price Target on Becton Dickinson and Co. to $188 From $175	MT
Aug. 07	RBC Adjusts PT on Becton Dickinson and Co. to $180 From $175, Maintains Sector Perform Rating	MT
Aug. 05	TD Cowen Adjusts Price Target on Becton, Dickinson and Company to $182 From $163	MT
Jul. 28	UBS Initiates Coverage on Becton, Dickinson and Company With Buy Rating, $190 Price Target	MT
Jul. 14	Goldman Sachs Adjusts Price Target on Becton, Dickinson and Company to $152 From $150, Maintains Neutral Rating	MT
Jul. 09	Waters Seen Benefiting From BD Turnaround, Pharma Manufacturing Tailwinds, RBC Says	MT
Jul. 06	Evercore ISI Adjusts Price Target on Becton, Dickinson and Company to $180 From $190	MT
Jun. 12	BofA Adjusts Price Target on Becton, Dickinson and Company to $170 From $177	MT
May. 27	Goldman Sachs Adjusts PT on Becton, Dickinson and Co. to $150 From $156, Maintains Neutral Rating	MT
May. 08	Becton, Dickinson Building Growth After 'Clean' Fiscal Q2 Beat, RBC Says	MT
May. 07	Evercore ISI Adjusts Price Target on Becton, Dickinson and Company to $190 From $180	MT
May. 07	Stifel Nicolaus Adjusts Becton, Dickinson and Company Price Target to $175 From $215	MT
May. 04	TD Cowen Adjusts Price Target on Becton, Dickinson and Company to $163 From $189, Maintains Hold Rating	MT
May. 04	U.S. research roundup - Alphabet, Colgate-Palmolive, Welltower	RE
Apr. 17	Piper Sandler Adjusts Becton, Dickinson and Company PT to $159 From $170, Maintains Neutral Rating	MT
Apr. 14	RBC Cuts Price Target on Becton, Dickinson to $175 From $195, Keeps Sector Perform Rating	MT

More recommendations

Other Medical Equipment, Supplies & Distribution

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ABBOTT LABORATORIES					+14.23%
	MEDTRONIC PLC					+14.01%
	CENCORA, INC.					+14.22%
	HOYA CORPORATION					+31.84%
	BECTON, DICKINSON AND COMPANY					+8.82%
	DEXCOM, INC.					+12.21%
	MEDLINE INC.					+30.98%
	WEST PHARMACEUTICAL SERVICES, INC.					+20.31%
	TERUMO CORPORATION					+38.48%
	Average					+20.57%
	Weighted average by Cap.					+17.24%